US 9938339
Method for treating an eye disease or disorder by administering an antibody that binds angiopoietin-2
granted A61KA61K2039/505A61K31/513
Quick answer
US patent 9938339 (Method for treating an eye disease or disorder by administering an antibody that binds angiopoietin-2) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/505, A61K31/513, A61K38/1866, A61K38/1891